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Alnumycin is closely related to the benzoisochroma-
nequinone (BIQ) polyketides such as actinorhodin.
Exceptional structural features include differences in
aglycone tailoring that result in the unique alnumycin
chromophore and the existence of an unusual 4-hy-
droxymethyl-5-hydroxy-1,3-dioxan moiety. Cloning
and sequencing of the alnumycin gene cluster from
Streptomyces sp. CM020 revealed expected biosyn-
thesis genes for polyketide assembly, but several
genes encoding subsequent tailoring enzymes were
highly atypical. Heterologous expression studies
confirmed that all of the genes required for alnumycin
biosynthesis resided within the sequenced clone.
Inactivation of genes aln4 and aln5 showed that the
mechanism of pyran ring formation differs from acti-
norhodin and granaticin pathways. Further inactiva-
tion studies identified two genes, alnA and alnB,
involved in the synthesis and attachment of the
dioxan moiety, and resulted in the production of the
polyketide prealnumycin.
INTRODUCTION
Alnumycin (1, Figure 1) is an aromatic polyketide antibiotic first
isolated in 1998 from Streptomyces sp. DSM 11575 (Bieber
et al., 1998) and Streptomyces griseorubiginosus strain Mer-
K1115, under the name K1115 B1 (Naruse et al., 1998). It was
shown to have several biological activities, including antibiotic,
cytostatic, gyrase inhibitory, and topoisomerase inhibitory (Bjo¨rn
and Jo¨rg, 1998). Structurally, alnumycin is an isochromanequi-
none compound, closely related to the benzoisochromanequi-
none (BIQ) polyketides, such as actinorhodin (2), medermycin
(3), granaticin (4), and frenolicin (5), whose biosynthetic path-
ways have been characterized in detail over the years (Caballero
et al., 1991; Bibb et al., 1994; Fernandez-Moreno et al., 1991,
1992, 1994; Hallam et al., 1988; Ichinose et al., 1998, 2003).
There are, however, several unusual features in the structure of
alnumycin, which makes it an intriguing research target. First,
the chiral carbon at position 2 (carbon 3 in polyketide number-
ing), which is characteristically found in all BIQ metabolites, is1046 Chemistry & Biology 15, 1046–1057, October 20, 2008 ª2008missing as a result of a double bond between carbons 2 and 3
(Figure 1). Second, unlike in BIQ pathways, the first carbon of
the polyketide chain is missing as a result of decarboxylation
during biosynthesis. Third and foremost, alnumycin contains
a sugar-like 4-hydroxymethyl-5-hydroxy-1,3-dioxan moiety,
which is highly uncommon in natural products, and there is no
previous knowledge about its biosynthesis.
Studies on the biosynthetic pathways of BIQ antibiotics have
produced a remarkable amount of information on formation of
polyketide aglycones, (Hopwood, 1997; Hertweck et al., 2007)
and structural studies on the actinorhodin ketoacyl synthase
heterodimer (Keatinge-Clay et al., 2004), acyl carrier protein
(Crump et al., 1997), ketoreductase (Hadfield et al., 2004; Kor-
man et al., 2004), and monooxygenase (Sciara et al., 2003)
proteins have clarified in great detail many issues concerning
polyketide biosynthesis. Furthermore, stereochemical control
of third ring cyclization has also been under thorough investi-
gation in the actinorhodin, granaticin, and medermycin path-
ways (Taguchi et al., 2001, 2004; Li et al., 2005), and use of
longer starter units has been shown in the R1128 biosynthetic
pathway (Pan et al., 2002; Marti et al., 2000). However, despite
this vast amount of work, there remain unanswered questions
regarding the function of several common ‘‘unknown’’ genes
found from BIQ pathways. These include, for instance, the
possible role of ActVI-OrfA in either cyclization (Fernandez-
Moreno et al., 1994) or transcription regulation (Taguchi
et al., 2007) and the exact roles of actVA gene products in
tailoring reactions in actinorhodin biosynthesis (Caballero
et al., 1991).
The combination of a biosynthetically familiar polyketide
skeleton coupled to an unusual tailoring pattern prompted us
to investigate the underlying alnumycin biosynthetic pathway
to shed light into formation of the pyran ring and synthesis of
the dioxan moiety. Here, we report the cloning and sequencing
of a gene cluster responsible for alnumycin biosynthesis from
Streptomyces sp. CM020 and heterologous expression of the
gene cluster in Streptomyces albus (Chater and Wilde, 1980).
In addition, structural elucidation of metabolites from four
blocked pathway mutants yields insights into third ring cycliza-
tion and biosynthesis of the dioxan moiety. Knowledge about
the gene products involved in dioxan synthesis and attachment
sets the ground for interesting combinatorial biosynthesis possi-
bilities regarding the use of this building block in generating BIQ
compound analogs.Elsevier Ltd All rights reserved
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Cloning, Sequencing, and Heterologous Expression
of the Alnumycin Biosynthetic Gene Cluster
A homologous hybridization probe was generated by PCR using
a set of degenerate primers designed to amplify KSa gene frag-
ments from actinomycetes (Metsa¨-Ketela¨ et al., 2002). Phyloge-
netic analysis revealed that the sequence amplified from Strep-
tomyces sp. CM020 clustered with KSa genes from known BIQ
antibiotic pathways (data not shown). Such similarity was ex-
pected for alnumycin biosynthetic genes, and therefore the
PCR product was used to screen a genomic cosmid library
constructed in vector pFD666 as described in Experimental
Procedures.
Sequencing of a 31.6 kb region from cosmid p020P1 revealed
unique NheI-SpeI restriction sites that were used to repackage
a 29.9 kb fragment from the cluster into the shuttle cosmid vector
pKC505 (Richardson et al., 1987) for expression studies. The oriT
origin of replication was sequentially cloned into the shuttle
Figure 1. Structures and Carbon Number-
ing
Alnumycin (1); the BIQ metabolites actinorhodin
(2), medermycin (3), granaticin (4), and frenolicin
(5); prealnumycin (6); K1115 A (7); and 3,8-dihy-
droxy-1-methylanthraquinone-2-carboxylic acid
(DMAC; 8).
cosmid by homologous recombination
in E. coli to allow intergenic conjugation
of the resulting expression cosmid
pAlnuori into Streptomyces albus (Chater
and Wilde, 1980). Cultivation of trans-
formants in E1soy medium supple-
mented with XAD-7 resin resulted in the
production of alnumycin, which was
confirmed by HPLC-UV/Vis and LC-MS
monitoring (Figure 2) by comparative
analysis against the metabolic profile of
the producing strain Streptomyces sp.
CM020.
Organization of the Genomic
Region Involved in Alnumycin
Biosynthesis
Analysis of a 31 kb DNA sequence with
the program Artemis (Rutherford et al.,
2000) revealed the presence of 32 open
reading frames (ORFs) that could be
involved in alnumycin biosynthesis. Two
of these (Figure 3, left) were omitted
from the expression cosmid pAlnuori,
indicating that alnR1 and aln1 are not ab-
solutely required for alnumycin synthesis,
but their involvement in, for instance, reg-
ulation of biosynthesis in the native host
cannot be ruled out. Based on sequence
comparisons with database proteins, 22
probable structural genes and 10 genes
possibly involved in regulation and transport were identified. Pu-
tative functions for the gene products, which are summarized in
Table 1, were assigned by BLAST searches (Altschul et al., 1990)
and gene inactivation experiments (see text herein).
Genes Involved in Polyketide Synthesis
The carbon skeletons of aromatic type II polyketides are synthe-
sized by the iterative action of minimal PKS complexes, which
consist of a b-ketoacyl synthase heterodimer (KSa and KSb/
CLF) that catalyzes the condensation of malonyl-CoA substrates
and an acyl carrier protein (ACP) onto which the growing polyke-
tide is tethered during synthesis (Hopwood, 1997; Hertweck
et al., 2007). In systems that employ starter units other than
acetyl-CoA, a combination of similar gene products (a b-ketoacyl
synthase III, an acyl transferase and another ACP) is used to
synthesize a starter unit of specific length (Marti et al., 2000;
Meadows and Khosla, 2001; Tang et al., 2004). The structure
of alnumycin suggested that it is synthesized from a four-carbon
butyryl-CoA starter unit, and in accordance a full set of starterChemistry & Biology 15, 1046–1057, October 20, 2008 ª2008 Elsevier Ltd All rights reserved 1047
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Alnumycin Biosynthetic Gene ClusterFigure 2. Monitoring of Metabolites Produced by Wild-
Type and Recombinant Strains
HPLC-UV-Vis profiles at 298 nm of crude extracts from (A) wild-
type Streptomyces sp. CM020, (B) S. albus/pAlnuori, (C) S. albus/
pAoriDaln4, (D) S. albus/pAoriDaln5, (E) S. albus/pAoriDind, and
(F) S. albus. Results from LC-MS analysis in positive mode are
also shown for (A) and (B).1048 Chemistry & Biology 15, 1046–1057, October 20, 2008 ª2008 Elsevier Ltd All rights reserved
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Alnumycin Biosynthetic Gene ClusterFigure 3. Organization of the aln Biosynthetic Gene Cluster
PKS genes responsible for polyketide carbon skeleton synthesis are marked in black; genes responsible for post-PKS tailoring reactions are white; genes of un-
known function are dark gray; and genes involved in regulation/resistance are light gray.unit genes were discovered from the cluster. The starter unit
ketosynthase alnI was found to reside apart from the rest of
the PKS genes separated by 22 kb from the starter unit acyl
transferase alnK (Figure 3). The starter unit ACP alnJ resided
next to alnK. In general, genes encoding starter and minimal
PKS (minPKS, alnLMN) subunits were most similar to those
found from the frenolicin pathway reflecting the same chain
length of these compounds (Bibb et al., 1994).
After the formation of the polyketide chain, the biosynthesis
continues by the action of a ketoreductase (KR, alnP) at C-9, fol-
lowed by aromatization of the first ring by an aromatase (ARO,
alnQ) and formation of the second ring in a controlled manner be-
tween C-5 and C-14 by a specific cyclase (CYC, alnR). The gene
products involved in these reactions are typically highly con-
served, and the aln gene products were in complete agreement
with findings from the BIQ pathways. The product of the second
ring cyclization is a bicyclic intermediate that can be said to define
the end of the PKS part of the pathway (Ichinose et al., 2003).
Identification of Genes Involved in Pyran Ring Formation
Though genes encoding PKS steps were highly conserved in the
alnumycin cluster, genes putatively responsible for post-PKS tai-
loring reactions held, in general, little resemblance to the genes
found in the other BIQ clusters. The next biosynthetic step on
BIQ pathways is the stereospecific reduction at C-3, which ulti-
mately controls the stereochemistry of the two chiral centers,
leading to (3S, 15R) configuration in actinorhodin and (3R, 15S)
in granaticin (Figure 1). In the actinorhodin and granaticin path-
ways, proteins belonging to different enzyme families have
been shown to catalyze the ketoreduction step (Taguchi et al.,
2001, 2004), but remarkably, no gene products homologous to
either of these were found from the alnumycin cluster. The
most likely candidate for the ketoreduction step was aln4, which
is similar in amino acid sequence to aldo-keto reductases (Table
1). Considering that the actinorhodin C-3 ketoreductase ActVI-
ORF1 has been shown to use NADPH as a cofactor (Itoh et al.,
2007), it is noteworthy that the aldo-keto reductase superfamily
contains several NADPH-dependent members.
On the actinorhodin pathway, it has been proposed that hemi-
ketal formation after C-3 ketoreduction might be spontaneous,
but enzymatic catalysis of both the ring closure and the subse-
quent dehydration would be necessary for efficient pyran ring
formation in vivo (Ichinose et al., 1999). However, no obvious
gene products were discovered from the alnumycin cluster
that could catalyze the cyclization and dehydration steps. For
the cyclization step, a possible candidate was the gene productChemistry & Biology 15, 1046–of aln5, which is similar (46%) in sequence to the C-terminal
domain of a modular polyketide synthase enzyme StiJ from
Stigmatella aurantiaca. The domain in StiJ is, however, unusual,
and it is not related to thioesterase (TE) domains, which normally
are responsible for cyclization reactions in modular type I PKS
pathways.
To obtain experimental evidence for the involvement of aln4
and aln5 in alnumycin biosynthesis, both genes were individually
inactivated from the shuttle cosmid pAlnuori by homologous
recombination in E. coli (Datsenko and Wanner, 2000). The re-
sulting expression constructs were transformed into the heterol-
ogous host S. albus by conjugation to obtain the mutant strains
S. albus/pAoriDaln4 and S. albus/pAoriDaln5. The production
profiles of the two mutant strains were found to be identical by
HPLC-UV/Vis monitoring (Figure 2), which showed a single
main metabolite peak that was clearly distinct from alnumycin.
For structural elucidation of the metabolite, S. albus/pAoriDaln5
was cultivated in a large scale, and the compound was purified
by chloroform extraction, column chromatography, and prepar-
ative HPLC. The molecular formula C18H14O6 was verified by
EI-HR-MS (m/z observed 326.078200, calculated 326.079038),
and the 1H and 13C NMR spectra were found to be similar to
those of K1115 A (7, Figure 1; Naruse et al., 1998). The structure
was confirmed using 1H1-H COSY, HSQC, and HMBC tech-
niques (data not shown). In essence, the evidence presented
here suggests that K1115 A is a shunt product from the alnumy-
cin pathway analogous to 3,8-dihydroxy-1-methylanthraqui-
none-2-carboxylic acid (DMAC) from the actinorhodin pathway
(McDaniel et al., 1993).
Probable Post-PKS Genes
In the actinorhodin pathway, quinone formation is the next bio-
synthetic step, which has been shown to proceed through the
action of anthrone oxidase ActVA-6 (Sciara et al., 2003), followed
by the action of the two-component FMN monooxygenase sys-
tem of ActVA-ActVB that is responsible for hydroxylation at C-8
(Valton et al., 2006). In addition, early mutagenesis studies sug-
gest that the actVA-3 gene product has some role during the ox-
idative tailoring of actinorhodin intermediates (Caballero et al.,
1991). In the alnumycin cluster, no genes homologous to the ac-
tinorhodin monooxygenase could be found. Gene products that
could be assigned to this part of the biosynthetic pathway with
confidence were the AlnT and AlnH pair that resembled the acti-
norhodin ActVA-ActVB system, respectively, and Aln6 and Aln7,
which showed similarity to each other and to ActVA-3 from the
actinorhodin pathway. In conclusion, the set of tailoring genes1057, October 20, 2008 ª2008 Elsevier Ltd All rights reserved 1049
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Closest Sequence Similarity
Protein Size (aa) Category Function Protein, Origin Sim/Id (%) Accession No.
AlnR1 168 Regulation MarR family regulator TroR, Streptomyces
avermitilis MA-4680
69/53 NP_828826
Aln1 231 Unknown Unknown SCO5557A, Streptomyces
coelicolor A3(2)
55/45 NP_629692
Aln2 172 Unknown Unknown Francci3_4104, Frankia
sp. CcI3
54/40 YP_483181
AlnJ 84 PKS Starter unit acyl
carrier protein
FrnJ, Streptomyces
roseofulvus
72/56 AAC18105
AlnK 414 PKS Starter unit
acyl transferase
HedF, Streptomyces
griseoruber
54/42 AAP85359
AlnL 421 PKS Ketoacyl synthase a FrnL, Streptomyces
roseofulvus
86/76 AAC18107
AlnM 428 PKS Ketoacyl synthase b ZhuA, Streptomyces
sp. R1128
76/66 AAG30188
AlnN 84 PKS Acyl carrier protein FrnN, Streptomyces
roseofulvus
71/59 AAC18109
AlnP 263 PKS Ketoreductase ORF5, Streptomyces
antibioticus
79/68 CAC05675
AlnQ 331 PKS Cyclase/aromatase FrnQ, Streptomyces
roseofulvus
60/51 AAC18112
AlnR 311 PKS Cyclase FrnR, Streptomyces
roseofulvus
78/65 AAC18113
AlnT 413 Tailoring Hydroxylase LndZ5, Streptomyces
globisporus
65/52 AAR16420
AlnR2 198 Regulation TetR family regulator AcrR, Rhodococcus
sp. RHA1
56/40 YP_706368
Aln3 155 Unknown Unknown Franean1DRAFT_4417,
Frankia sp. EAN1pec
66/53 ABW11619
Aln4 354 Tailoring Ketoreductase CflavDRAFT_0972,
Bacterium Ellin514
68/50 ZP_02965856
AlnO 152 Tailoring Oxidoreductase, pyridoxine
50-phosphate oxidase
SCO1156, Streptomyces
coelicolor A3(2)
73/51 NP_625448
Aln5 176 Tailoring Involved in pyran
ring formation
Bcenmc03DRAFT_4709,
Burkholderia cenocepacia
MC0-3
50/37, 75 length ZP_01564599
Aln6 359 Tailoring Oxidase SwitDRAFT_4883,
Sphingomonas wittichii RW1
56/43 ZP_01606335
AlnB 227 Dioxan synthesis Phosphatase,
phosphoglycolate
phosphatase
IdgB, Pectobacterium
chrysanthemi
54/40 AAF74780
AlnA 306 Dioxan synthesis Involved in dioxan
synthesis/attachment
IdgA, Pectobacterium
chrysanthemi
67/50 AAF74779
Aln7 352 Tailoring Oxidase SwitDRAFT_4883,
Sphingomonas wittichii RW1
56/43 ZP_01606335
AlnR3 271 Regulation SARP family regulator Gra-orf9, Streptomyces
violaceoruber Tu22
71/59 CAA09630
Aln8 186 Unknown Unknown SAV2891, Streptomyces
avermitilis MA-4680
58/39 NP_824067
AlnT1 513 Export Transporter SCO3199, Streptomyces
coelicolor A3(2)
63/42 NP_627413
AlnR8 166 Regulation MarR family regulator SAP1p77, Streptomyces
avermitilis MA-4680
67/52 NP_828826
AlnR4 430 Regulation Two-component
sensory kinase
Gra-orf11, Streptomyces
violaceoruber Tu22
54/40 CAA096321050 Chemistry & Biology 15, 1046–1057, October 20, 2008 ª2008 Elsevier Ltd All rights reserved
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Closest Sequence Similarity
Protein Size (aa) Category Function Protein, Origin Sim/Id (%) Accession No.
AlnR5 201 Regulation Two-component
response regulator
NcnR, Streptomyces
arenae
75/60 AAD20272
AlnI 332 PKS Starter unit
ketoacyl synthase
FrnI, Streptomyces
roseofulvus
75/68 AAC18104
AlnH 180 Tailoring Flavin reductase FrnH, Streptomyces
roseofulvus
66/56 AAC18103
AlnR6 218 Regulation Two-component
response regulator
CitB, Streptomyces
sp. WA46
84/73 BAC78370
AlnR7 381 Regulation Two-component
sensory kinase
ORF20, Streptomyces
sp. Strain WA46
61/46 BAC78369
AlnT2 741 Export Transporter SCO3166, Streptomyces
coelicolor A3(2)
74/58 NP_627382typical to BIQ pathways that were present in the cluster were
identical to those found from the granaticin pathway.
Genes of Unknown Function
Several deduced gene products were discovered from the clus-
ter for which no function could be assigned based on sequence
information, but which might hold a role in post-PKS reactions.
Two of these, Aln3 and Aln8, had no sequence similarity to any
proteins of known function. Aln3 was found to be similar to a
protein AclJ of unknown function from the aclacinomycin biosyn-
thetic gene cluster, whereas Aln8 was most similar to hypothet-
ical protein SAV2891 from S. avermitilis.
The deduced gene product of aln2 was most similar (54%) to
a b-subunit of a proposed aromatic ring hydroxylating dioxyge-
nase from a Frankia species. Aln2 also held sequence similarity
(50%) to ActVI-ORFA from S. coelicolor A3(2) and to several
ActVI-ORFA homologs from Streptomyces species. ActVI-
ORFA has recently been shown to affect transcription of the actVI
genetic loci (Taguchi et al., 2007), and because of the sequence
similarity it is possible that Aln2 also has a regulatory role.
Inactivation of Genes Involved in Dioxan Biosynthesis
The gene cluster contained two apparently translationally cou-
pled genes alnA and alnB—which encoded proteins homolo-
gous to IndA and IndB, respectively—that have been implicated
to be involved in the biosynthesis of the blue pigment indigoidine
in Erwinia chrysanthemi (Reverchon et al., 2002). However, re-
cently it has been shown that indigoidine is synthesized solely
by an unusual nonribosomal peptide synthetase (NRPS) in
Streptomyces lavendulae (Takahashi et al., 2007). According to
sequence analysis, AlnB belongs to the haloacid dehalogenase
superfamily (HAD) (Kuznetsova et al., 2006), but no function
has been described for proteins homologous to AlnA. The crystal
structure of an IndA-like protein TM1464 from Thermotoga
maritima has recently been determined, which revealed an un-
identified ligand slightly larger than glycerol-3-phosphate in the
putative active site (Levin et al., 2005). In alnumycin biosynthesis,
erythritol phosphate would be an excellent building block for the
dioxan moiety and would be in agreement with the description of
the unknown ligand from TM1464. These observations promp-
ted us to delete alnA and alnB from the expression cosmid
pAlnuori by homologous recombination.Chemistry & Biology 15, 1046–1Transformation of S. albus with the mutated cosmid pAoriDind
resulted in the production of a novel metabolite as shown by
HPLC-UV/Vis analysis, in which the compound had the charac-
teristic spectrum of alnumycin, but a markedly different retention
time. Hence the compound was named prealnumycin (6, Fig-
ure 1). For full structural elucidation, the strain was cultivated in
larger scale and the compound was isolated by column chroma-
tography and preparative HPLC. The molecular formula of
prealnumycin (C17H16O4) was readily inferred by EI-HR-MS
(m/z observed 284.105500, calculated 284.104859). Literature
searches revealed that the 1H and 13C NMR spectra of 6 were
exceedingly similar to those of 1 (Table 2) except for the dioxan
part of the molecule for which the signals were missing. In agree-
ment, two aromatic proton signals at 6.83 ppm and 6.87 ppm,
which showed AB coupling because of their highly similar chem-
ical environment, confirmed that in place of the dioxan moiety
there was a single hydrogen at position 9 in 6.
To test the effect of individual alnA and alnB mutations, a two-
plasmid system was used to complement the double-knockout
mutant strain. First, the genes alnA and alnB were cloned
together into the high copy-number vector pIJ487 (Hopwood
et al., 1985) in Streptomyces lividans TK24, resulting in plasmid
pIJa7AB. Transformation of the plasmid to S. albus/pAoriDind
by protoplast transformation reestablished production of 1 (Fig-
ure 1) in levels comparable to S. albus/pAlnuori (data not shown).
Complementation with single genes in the vector pIJE486
(Ylihonko et al., 1996) did not have any effect on the production
profile, and 6 remained the main metabolite detected, confirming
that both gene products are required for biosynthesis and
attachment of the dioxan moiety.
Regulatory and Resistance Genes
A high number of putative regulatory genes were discovered to
reside in the gene cluster. In total, gene products from eight
ORFs held sequence similarity to proteins from known regulatory
families. These included two pairs, putatively AlnR4/AlnR5 and
AlnR7/AlnR6, of two-component sensory kinase/response regu-
lators; two proteins, AlnR1 and AlnR8, belonging to the MarR fam-
ily of regulators; and AlnR2, which was classified as a member of
the TetR family of DNA binding proteins (Table 1). Finally, AlnR3
had sequence similarity with the SARP family of pathway-specific
antibiotic biosynthesis activators (Wietzorrek and Bibb, 1997).057, October 20, 2008 ª2008 Elsevier Ltd All rights reserved 1051
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conservative as sequence analysis revealed two proteins, AlnT1
and AlnT2, that were homologous to transmembrane proteins.
DISCUSSION
Aromatic polyketides isolated from natural sources offer only
a few core polyketide aglycon structures, which are formed by
controlling starter unit selection, chain length formation, possible
ketoreduction, and regiochemistry of cyclization events (Hop-
wood, 1997; Hertweck et al., 2007). The enormous variety seen
in the structures of the metabolites isolated originates mostly
from numerous tailoring or post-PKS reactions (Rix et al.,
2002). Commonly these are subtle changes in functional groups
such as oxygenations, reductions, and methylations; glycosyla-
tion remains the most widely used means to generate major
structural changes to these compounds (Hertweck et al.,
2007). Other more drastic changes include rearrangements of
C-C bonds in the polyketide aglycones (Xu et al., 2005; Kharel
et al., 2007) and in some cases incorporation of more unusual
building blocks from other pathways (Trefzer et al., 2002). Clon-
ing of the genes responsible for alnumycin synthesis gives in-
sight both into the pyran ring formation and the biosynthesis of
the highly unusual dioxan moiety, which provides new interesting
possibilities for utilization of this building block in combinatorial
biosynthesis approaches (Rix et al., 2002; Reeves, 2003). Partic-
ularly, given the structural similarities, an obvious starting point
would be the replacement of the deoxysugar residue of meder-
Table 2. Observed NMR Signals from Prealnumycin (6) in
Chloroform-d1 and K1115 A (7) in Chloroform-d1:DMSO-d6 (5:1)
Prealnumycin (6) K1115 A (7)
1H NMR 13C NMR 1H NMR 13C NMR
1 1.96 (s) 20.4 169.0
2 158.4 129.5
3 5.60 (s) 100.0 159.1
4 139.5 7.76 (s) 112.7
5 7.12 (s) 114.4 136.7
6 131.2 182.1
7 184.5 132.1
8 6.83 (d) 138.8 7.71 (dd) 117.9
9 6.87 (d) 139.0 7.60 (t) 134.9
10 188.9 7.27 (dd) 124.1
11 112.9 13.13 (s, OH) 161.8
12 12.16 (OH) 156.8 116.7
13 122.3 188.9
14 5.65 (dd) 73.0 121.9
15 1.51 (m) 34.9 146.6
2.00 (m)
16 1.47 (m) 18.1 3.21 (m) 34.3
1.55 (m) 3.24 (m)
17 0.96 (t) 13.8 1.67 (m) 23.6
1.71 (m)
18 1.08 (t) 14.3
Carbon numbering is the same as that used in Figure 1.1052 Chemistry & Biology 15, 1046–1057, October 20, 2008 ª2008 Emycin (Figure 1) with the alnumycin dioxan moiety. Medermycin
has been shown to have a number of biological activities, includ-
ing cytotoxity against adriamycin-, aclarubicin- and bleomycin-
resistant cells (Brimble et al., 1999; Bililign et al., 2005); it would
therefore be interesting to see the effect of the dioxan moiety on
the activity.
Early Biosynthetic Steps Are Related
to the BIQ Pathways
Analysis of the alnumycin gene cluster reveals that the gene
products discovered are in agreement with the established
model for polyketide assembly (Figure 4). Especially, sequence
similarity with BIQ enzymes catalyzing early biosynthetic steps
was significant. From the widely accepted polyketide biosynthe-
sis model it can be deduced that first a four-carbon starter unit is
synthesized by AlnIJK in a manner analogous to R1128 biosyn-
thesis (Meadows and Khosla, 2001; Tang et al., 2004). No
gene products for reduction of the starter unit diketide could
be found and therefore it is probable that these activities are
borrowed from primary fatty acid metabolism. Following polyke-
tide chain synthesis by AlnLMN, the nascent carbon skeleton is
most likely reduced, aromatized, and cyclized by AlnP, AlnQ,
and AlnR, respectively, to generate the common bicyclic inter-
mediate found in the BIQ pathways (Figure 4).
A Novel Type of Ketoreductase Is Responsible
for the Pyran Ring Formation
After formation of the two-ring intermediate, the alnumycin bio-
synthetic pathway deviates from the traditional BIQ biosynthetic
routes. The gene inactivation experiments revealed two genes,
aln4 and aln5, involved in the next step, as disruption of either
of these genes completely abolished alnumycin formation and
caused the production of the shunt product K1115 A as the
sole main product (Figure 2). The result can be interpreted as
another remarkable example of the convergent evolution of anti-
biotic biosynthesis pathways; the alnumycin system presents
a third alternative solution for pyran ring formation in addition
to the two mechanisms identified previously on the actinorhodin
and granaticin pathways (Figure 5).
A likely difference in these three systems is that the Aln4 aldo-
keto reductase probably acts on the C-15 keto group instead of
the C-3 keto group that is reduced in BIQ biosynthesis (Figure 5;
Taguchi et al., 2004). The benefit of this model is the direct gen-
eration of a double bond between carbons 2 and 3 (carbons 3
and 4 in polyketide numbering in Figure 5), which is seen in the
structures of 1 and 6 (Figure 1) after subsequent cyclization
and dehydration steps. On the granaticin pathway, Gra-ORF5
and Gra-ORF6 are proposed to catalyze the ketoreduction at
C-3 in a cooperative manner, the former alone being a ketoreduc-
tase at C-9 (Ichinose et al., 2001). In an analogous fashion, the
relatively small-sized Aln5 might function as an accessory
protein for the reductase Aln4 on the alnumycin pathway.
Alnumycin Tailoring Reactions Proceed Through
Unusual Enzymatic Reactions
Following third-ring cyclization, the biosynthesis is likely to
continue by formation of the quinone moiety through hydroxyl-
ation at carbon 7 (carbon 8 in polyketide numbering in Figure 4)
by AlnT/AlnH and subsequent oxidation. The Aln6 and Aln7 genelsevier Ltd All rights reserved
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The carbon numbering shown is calculated beginning from the enzyme-bound carbon of the formed polyketide chain and differs from the carbon numbering of
the end product alnumycin.products might be involved in stabilization of the reactive inter-
mediates at this step, as has been proposed to occur in
actinorhodin biosynthesis (Caballero et al., 1991). It is interesting
to note, given the opposite order of the quinone and aromatic
rings, how an identical set of gene products to the granaticin
pathway is most likely responsible for the generation of the dis-
tinct alnumycin chromophore. Formation of the quinone moiety
requires oxidation, but whether this occurs nonenzymatically
or by AlnO, for instance, remains to be established. Likewise,
the timing and mechanism of decarboxylation of the nascent
polyketide cannot be deduced in silico (Figure 4). In many cases,
like in the pathways for angucyclic compounds (Kulowski et al.,
1999; Metsa¨-Ketela¨ et al., 2003) and the anthracycline steffimy-
cin (Gullon et al., 2006), decarboxylation occurs during last-ring
cyclization, whereas in the case of alnumycin this is unlikely as
a methylene group separates the carboxyl moiety from the
nascent ring. The alnumycin cluster has enough unassigned
ORFs (e.g., aln3 and aln8) to provide enzymes that could
catalyze reactions at this part of the biosynthetic pathway.
The gene inactivation studies indicated that the final biosyn-
thetic step is synthesis and attachment of the dioxan moiety
by alnA and alnB. Isolation of 6 from a blocked pathway mutant
suggests that the whole 4-hydroxymethyl-5-hydroxy-1,3-dioxan
moiety is synthesized prior to attachment and not constructed
directly on the alnumycin aglycone in a stepwise manner. Logi-
cally, formation of the dioxan moiety should proceed via acetalChemistry & Biology 15, 1046–formation between erythritol and formaldehyde in a manner anal-
ogous to the synthesis of 5-hydroxy-1,3-dioxan (Garcı´a et al.,
2000). The substrates for these reactions are most likely phos-
phorylated as the involvement of AlnB, which is homologous to
phosphatases, in the reactions implies. This is also supported
by the observation of the unknown phosphorylated ligand in
the crystal structure of TM1464 (Levin et al., 2005), which has
30% sequence identity with AlnA. It is possible that one of the
gene products catalyzes acetal formation while the other is
responsible for attachment of a complete dioxan moiety to the
alnumycin aglycone. No other potential candidates for dioxan
attachment could be found by sequence analysis, and, espe-
cially, no gene products homologous to glycosyl transferases,
which have been shown to catalyze C-aryl transfers (Bililign
et al., 2005), were identified within the gene cluster. The exact
nature of the substrates and the specific reactions catalyzed
by AlnA and AlnB are currently under in vitro investigations in
our laboratory.
SIGNIFICANCE
Alnumycin is an aromatic polyketide antibiotic related in
structure to the much-studied benzoisochromanoquinones
(BIQ) such as actinorhodin. Several atypical features in the
structure of alnumycin suggested that numerous biosyn-
thetic steps might proceed in an unusual manner, which1057, October 20, 2008 ª2008 Elsevier Ltd All rights reserved 1053
Chemistry & Biology
Alnumycin Biosynthetic Gene ClusterFigure 5. Comparison of Reactions Involved in Pyran Ring Formation in Actinorhodin, Granaticin, and Alnumycin Biosynthesis
R1 = CH3 and R2 = CH2CH2CH3. Multiple arrows indicate several biosynthetic steps.prompted us to investigate the underlying biosynthesis
pathway by molecular genetics.
Cloning, sequencing, and heterologous expression of the
alnumycin gene cluster isolated from Streptomyces sp.
CM020 confirmed the presence of a complete set of biosyn-
thetic genessufficient for alnumycinbiosynthesis. Sequence
analysis indicated that early biosynthetic steps were in
agreementwith the establishedmodel for polyketide assem-
bly, but several genes encoding subsequent tailoring en-
zymes were highly atypical. No genes homologous to those
encoding ketoreductases involved in pyran ring formation
in either actinorhodin or granaticin pathways were present.
Inactivation studies confirmed that on the alnumycin path-
way the ketoreduction step is catalyzed by a gene product
homologous to aldo-keto reductases. This surprising finding
confirms that on related antibiotic biosynthesis pathways,
proteins belonging to three different enzyme families cata-
lyze a highly similar biosynthetic step.
The most remarkable feature of alnumycin is the sugar-
like 4-hydroxymethyl-5-hydroxy-1,3-dioxan moiety attached
to the aglycone. The structure is highly unusual in natural
products, and no previous information exists about the
underlying biosynthetic pathway. Gene inactivation experi-
ments identified two genes, alnA and alnB, involved in its
biosynthesis. The finding suggests that the entire dioxan1054 Chemistry & Biology 15, 1046–1057, October 20, 2008 ª2008moiety is synthesized prior to attachment and not con-
structed in a stepwise manner directly to the aglycone.
The work presented here sets the ground for more
detailed mechanistic studies on the unusual biosynthetic
enzymes and opens up interesting combinatorial possibili-
ties for use of the dioxan moiety in the generation of natural
product diversity via pathway engineering.
EXPERIMENTAL PROCEDURES
Strains and Culture Conditions
The alnumycin producing Streptomyces sp. CM020 was obtained from Gali-
laeus Oy (Kaarina, Finland). Streptomyces albus (Chater and Wilde, 1980)
and Streptomyces lividans TK24 (Hopwood et al., 1985) were used as heterol-
ogous hosts. For production of metabolites, Streptomyces species were cul-
tivated in modified E1 medium (Ylihonko et al., 1994), where soy flour (grocery
store grade) was used instead of Pharmamedia, for 4–5 days at approximately
300 rpm at 28C. Amberlite XAD-7 (1 g/50 ml) was added for adsorption of
metabolites from cultivation media. For generation of S. albus protoplasts, cul-
tures growing for 1–3 days in TSB media (Oxoid; Cambridge, UK), including
5 mM MgCl2 and 0.5% glycine, were combined, whereas S. lividans TK24
was grown in YEME media (Hopwood et al., 1985) supplemented with 0.5%
glycine for 3 days. Protoplasts were regenerated on R2YE plates. MS (Kieser
et al., 2000) and ISP4 plates (Difco; Detroit, MI) were used for storage on solid
medium. Apramycin (Fluka; Buchs, Switzerland) at 50 mg/ml and thiostrepton
(Calbiochem; San Diego) at 50 mg/ml and 40 mg/ml were used for selection in
solid and liquid media, respectively.Elsevier Ltd All rights reserved
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(Invitrogen; Carlsbad, CA) were used as cloning hosts. Transformation of S. al-
bus by intergenic conjugation was conducted using E. coli ET12567/pUZ8002
(Kieser et al., 2000). E. coli strains were cultivated in LB medium supplemented
with appropriate antibiotics for selection of plasmids and cosmids.
General DNA Techniques
Isolation of plasmid and cosmid DNA from Streptomyces species was
performed using conventional techniques. Restriction enzyme-digested frag-
ments were recovered from agarose gels by QIAquick Gel Extraction Kit
(QIAGEN; Venlo, The Netherlands), and plasmid DNA from E. coli was isolated
using QIAprep Spin Miniprep Kit (QIAGEN). Phusion DNA Polymerase
(Finnzymes; Espoo, Finland) was used in PCR amplification reactions accord-
ing to manufacturer’s instructions. Southern hybridization was performed using
a DIG-labeled (Roche; Switzerland) probe amplified by PCR with degenerated
primers designed to amplify part of the KSa gene (Metsa¨-Ketela¨ et al., 2002).
Cloning and Sequencing of the Alnumycin Gene Cluster
The genomic DNA of Streptomyces sp. CM020 was isolated by standard
procedures (Kieser et al., 2000). For construction of a genomic library, DNA
was partially digested with Sau3AI, ligated into cosmid vector pFD666
(ATCC) digested with BamHI and packaged using Gigapack III XL (Stratagene).
Thirteen positive colonies were chosen from colony hybridization for further
screening by restriction analysis, and the cosmid p020P1 was selected for
sequencing. Both strands of an area of 31.6 kb were completely sequenced
using a transposon-based Template Generation System (Finnzymes) and an
automatic ABI 310 DNA sequencer (Applied Biosystems; Foster City, CA).
ORFs were detected with the program Artemis (Rutherford et al., 2000), and
Vector NTI Suite version 9.0 (Invitrogen) was used for sequence analysis. All
restriction enzymes were purchased from Fermentas (Vilnius, Lithuania).
Construction of Expression Cosmids
Most of the alnumycin gene cluster was cloned into an E. coli-Streptomyces
shuttle vector pKC505 (Kieser et al., 2000) for heterologous expression in
Streptomycetes. The cosmid p020P1 was digested with NheI and SpeI and
the 29.9 kb Klenow treated (Fermentas) digestion product was ligated into
pKC505 digested with HpaI and BamHI; Klenow treated and dephosphory-
lated; and repackaged using Gigapack III XL (Stratagene). The resulting cos-
mid pAlnu lacked the oriT origin of replication required for transformation
by conjugation from E. coli to Streptomyces. For this purpose, the aac(3)IV
region of pKC505 in pAlnu was substituted by an aac(3)IV oriT fragment, which
was generated by PCR using pSET152 (Kieser et al., 2000) as a template. The l
Red recombinase system (Datsenko and Wanner, 2000) using homologous
recombination was used for the substitution, which was performed in
two steps. First, 70 nt and 69 nt primers were designed to amplify the gene
coding for chloramphenicol acetyl transferase, using the plasmid pKD3
(Datsenko and Wanner, 2000) as a template: pkccmfor (50)GTCACGCTGAAA
ATGCCGGCCTTTGAATGGGTTCATGTGCAGCTCCATCAGATCGGCACGTA
AGAGGTTC and pkccmrev (50)CAGCGCGACCTTGCCCCTCCAACGTCATC
TCGTTCTCCGCTCATGAGAGAATAGGAACTTCGGAATAGG. The 50 ends of
the primers consisted of 50 nt segments homologous to aac(3)IV region. The
0.9 kb-long PCR product was used for homologous recombination in E. coli
TOP10 transformed with pAlnu and the helper plasmid pKD46 (Datsenko
and Wanner, 2000) to substitute the aac(3)IV area by the chloramphenicol
resistance cassette generating pAlnucmR. Second, the chloramphenicol resis-
tance cassette was substituted in a similar manner by a fragment containing
both aac(3)IV and oriT. The fragment was generated by PCR using the primers
aprorifor (50 )GATCGGCACGTAAGAGGTTCCAACTTTCACCATAATGAAATAA
GATCACTCATCAGCAAAAGGGGATGAT and aprorirev (50)GCCCTGCCACTC
ATCGCAGTACTGTTGTATTCATTAAGCATCTGCCGACAGCCAAAGGGTTCG
TGTAGAC, and pSET152 as a template. E. coli TOP10, including pAlnucmR
and pKD46, was transformed with the 0.75 kb-long PCR product resulting in
pAlnuori.
Inactivation of aln4, aln5, alnA, and alnB and Construction
of the Complementation Plasmids
The ORFs aln4, aln5, alnA, and alnB were deleted from the cosmid pAlnuori
again using the l Red recombinase system (Datsenko and Wanner, 2000).Chemistry & Biology 15, 1046–The primers consisted of 50 nt homology region followed by 20 nt priming se-
quence for amplifying of the cmR area with flanking FRT (FLP recognition tar-
get) sites: aln4fcamfor
(50)GTGCGCTACACGCTTCTCGGCAGGACCGGGGTCCGGATATCCCGG
CTGGCGTGTAGGCTGGAGCTGCTTC (start codon underlined) and aln4f-
camrev
(50)GTTCAGGCACCGCACTCCCGGAGGAGGAGCGCTCAGGCGGCCCC
GTACCGATGGGAATTAGCCATGGTCC. The resistance gene was subse-
quently eliminated using the helper plasmid pFLP2 (Hoang et al., 1998) ex-
pressing FLP recombinase, leaving behind a fragment consisting of 50 bp
from the 50 end of aln4, a 103 bp scar sequence, and 18 bp from the 30 end
in place of aln4 in pAoriDaln4.
The inactivation of ORF aln5 was performed similarly, using the primers
aln5fcamfor
(50)CCGGAGGAGGTCGTCGGAGTGTGGCGGCTGGCCTCGTACACGGAG
GTGGGGTGTAGGCTGGAGCTGCTTC and aln5fcamrev
(50)GTGCGTCTCCTTCTCCTGCTGTTCCGCCGTCTCGTCGGACGCCGTG
CTGTATGGGAATTAGCCATGGTCC. Elimination of the resistance gene re-
sulted in a fragment with 56 bp from the 50 end of aln5, the 103 bp scar
sequence, and 53 bp from the 30 end in place of aln5 in pAoriDaln5.
The overlapping genes alnA and alnB in the cosmid pAlnuori were inacti-
vated in a similar manner as aln4 and aln5, using the primers indfor (50)CATGG
AACGACAGCCCGACCAGCTGCTAGAGGTCAGCGACGAGATCGCCAGTGT
AGGCTGGAGCTGCTTC (start-codon underlined) and indrev (50)GTCGTCG
CCCGCGATGACCGTCAGCCGGGTGTCCAGACCGGTGAGTTCGG
ATGGGAATTAGCCATGGTCC. FLP recombinase-mediated elimination of
the resistance gene left behind 49 bp from the 50 end of alnA, the 103 bp
scar sequence, and 302 bp from the 30 end of alnB in place of alnA and
alnB. The resulting cosmids pAoriDaln4, pAoriDaln5 and pAoriDind were intro-
duced into S. albus by intergenic conjugation. All S. albus mutant strains were
verified by restriction analysis of cosmid DNA, which was first introduced back
into E. coli.
For complementation of the pAoriDind double mutant with individual genes,
plasmids pIJEHaA and pIJEHaB were constructed. Insert DNA was derived
from plasmids pBDHaA and pBDHaB that were designed for recombinant pro-
tein production in E. coli, and each contains a PCR-amplified and sequenced
gene cloned into a modified pBADHisB (Invitrogen) vector (Kallio et al., 2006).
Plasmid pBDHaA was digested with BamHI and HindIII, and the 1.04 kb insert
fragment was cloned into similarly digested pIJE486 to obtain pIJEHaA in
S. albus/pAoriDind. Plasmid pBDHaB was also digested with BamHI and
HindIII, resulting in a 0.6 kb BamHI fragment and a 0.2 kb BamHI-HindIII frag-
ment, which were cloned in a three-way ligation into pIJE486 in S. albus/
pAoriDind. Plasmid pIJEHaB was constructed via transformation of S. lividans
TK24, and finally, S. albus/pAoriDind was transformed with plasmid isolated
from S. lividans TK24/pIJEHaB.
An 11.7 kb BglII fragment from the cosmid p020P1 was cloned into pBlue-
script (Fermentas) digested with BamHI, resulting in plasmid pB020P1B1.2,
and a blunt ended 4.6 kb PagI fragment from pB020P1B1.2 was cloned into
pBluescript digested with EcoRV. The latter plasmid was digested with XbaI
and HindIII, and the 3.9 kb insert fragment, including alnA, alnB, and aln7,
was cloned into the Streptomyces vector pIJ487 (Hopwood et al., 1985)
digested with XbaI and HindIII in S. albus/pAoriDind, resulting in plasmid
pIJa7AB.
Analysis of Metabolites
From cultivations with XAD-7, the resin was separated from the culture broth
by repeated decanting, and the compounds were extracted with acetonitrile
for further analysis. Samples fromS. albus/pAoriDaln4 andS. albus/pAoriDaln5
cultivations were extracted under acidic conditions. HPLC samples were
analyzed with a Shimadzu SCL-10Avp (Shimadzu; Kyoto, Japan) with a Merck
LiChroCART 250-4 RP-18 (5 mm) column using a 18 min gradient from 50% to
99% acetonitrile in 0.1% formic acid.
Purification and Structural Determination
of K1115 A and Prealnumycin
For large-scale production of metabolites, S. albus/pAoriDaln5 was cultivated
for 7 days in 250 ml, 500 ml, and 1 l flasks (total volume 6 l), where XAD was
added 1 day prior to harvesting. XAD and whole cells were collected by1057, October 20, 2008 ª2008 Elsevier Ltd All rights reserved 1055
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Alnumycin Biosynthetic Gene Clustercentrifuging, and the pellets were stored at 20C until extraction with ace-
tone. K1115 A was purified by repeated chloroform extraction in both neutral
and acidic conditions, followed by silica gel chromatography in chloroform
using a methanol gradient from 5% to 30%. As a final step, K1115 A was
purified by preparative HPLC with a Merck Hitachi L-6200A using a LiChros-
pher 100 RP-18 (10 mm) column and a 45 min acetonitrile gradient from 50%
to 100% in 0.1% formic acid.
For production of metabolites, S. albus/pAoriDind was grown in 250 ml and
500 ml flasks (total volume 6 l). The compounds were extracted from XAD us-
ing a water:isopropanol gradient. Prealnumycin was subsequently subjected
to repeated silica gel chromatography using a chloroform:methanol gradient
and LH-20 size exclusion chromatography using dichloromethane:tetrahydro-
furan (20:5) as the eluent. As a final step, prealnumycin was purified by prepar-
ative HPLC with a Merck Hitachi L-6200A using a Phenomenex Phenyl-Hexyl
250-10 (10 mm) column and a 30 min acetonitrile gradient from 15% to 100%.
LC-MS and NMR Measurements
Analytical samples were analyzed by LC-ESI-MS (Perkin-Elmer Sciex API 365
triple quadrupole mass spectrometer) using the same column and conditions
as in other HPLC measurements. High-resolution EI-HR-MS data was col-
lected with Micromass ZAB-oa-TOF mass spectrometer. NMR spectra were
obtained with a Bruker Avance 400 MHz NMR spectrometer. 1H and 13C
NMR chemical shifts are referenced to tetramethylsilane.
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